Celularity Net Debt from 2010 to 2024

CELU Stock

USD 2.76 0.09 3.16%

Celularity Net Debt yearly trend continues to be comparatively stable with very little volatility. Net Debt is likely to outpace its year average in 2024. Net Debt is the total debt of Celularity minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2019-03-31

Previous Quarter

65.2 M

Current Value

31.1 M

Quarterly Volatility

30.2 M

Covid

Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Interest Expense of 2.8 M, Ebit of 17.2 M or Net Income Applicable To Common Shares of 17.1 M, as well as many indicators such as Price To Sales Ratio of 1.84, Dividend Yield of 0.0 or PTB Ratio of 1.13. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.

Check out the analysis of Celularity Correlation against competitors.

For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Latest Celularity's Net Debt Growth Pattern

Below is the plot of the Net Debt of Celularity over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Celularity's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Celularity's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Celularity Net Debt Regression Statistics

	Arithmetic Mean	8,673,219
	Geometric Mean	1,061,902
	Coefficient Of Variation	240.10
	Mean Deviation	16,540,102
	Median	125,293
	Standard Deviation	20,824,037
	Sample Variance	433.6T
	Range	75.3M
	R-Value	0.56
	Mean Square Error	318.8T
	R-Squared	0.32
	Significance	0.03
	Slope	2,622,920
	Total Sum of Squares	6071T

Celularity Net Debt History

	2024	41 M
	2023	39 M
	2022	51.6 M
	2021	-6.1 M
	2020	-23.7 M
	2019	27.1 M

Other Fundumenentals of Celularity

Net Debt To E B I T D A

Celularity Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Good Will	Capital Surpluse	Intangible Assets	Current Deferred Revenue	Deferred Long Term Liab	Net Invested Capital	Capital Stock	Net Working Capital	Short Term Debt	Short Long Term Debt
Total Assets		-0.08	0.76	0.22	-0.68	0.22	0.46	0.74	0.83	0.27	0.88	-0.09	0.79	-0.58	-0.55	-0.04	0.58	0.49	-0.32	0.28	0.04
Total Stockholder Equity	-0.08		-0.37	0.64	0.08	0.07	-0.14	-0.73	-0.53	0.42	0.0	-0.08	-0.17	0.08	-0.32	-0.08	0.34	0.31	-0.26	0.24	0.07
Net Tangible Assets	0.76	-0.37		0.28	-0.94	0.57	0.84	0.77	0.94	-0.25	0.86	-0.53	0.94	-0.9	-0.71	-0.47	0.72	0.71	-0.66	0.63	0.44
Net Debt	0.22	0.64	0.28		-0.5	0.39	0.52	-0.28	0.02	0.25	0.49	-0.63	0.35	-0.55	-0.67	-0.58	0.7	0.73	-0.84	0.86	0.55
Retained Earnings	-0.68	0.08	-0.94	-0.5		-0.75	-0.89	-0.52	-0.78	0.19	-0.9	0.72	-0.94	0.98	0.9	0.64	-0.89	-0.9	0.83	-0.79	-0.6
Accounts Payable	0.22	0.07	0.57	0.39	-0.75		0.84	0.11	0.32	-0.28	0.6	-0.78	0.7	-0.78	-0.78	-0.57	0.69	0.83	-0.71	0.65	0.47
Net Receivables	0.46	-0.14	0.84	0.52	-0.89	0.84		0.42	0.62	-0.27	0.78	-0.77	0.88	-0.91	-0.79	-0.58	0.75	0.86	-0.85	0.82	0.5
Total Liab	0.74	-0.73	0.77	-0.28	-0.52	0.11	0.42		0.93	-0.09	0.61	-0.01	0.66	-0.45	-0.16	0.02	0.17	0.13	-0.05	0.03	-0.02
Total Current Assets	0.83	-0.53	0.94	0.02	-0.78	0.32	0.62	0.93		-0.15	0.79	-0.26	0.85	-0.72	-0.49	-0.24	0.5	0.45	-0.38	0.35	0.24
Common Stock	0.27	0.42	-0.25	0.25	0.19	-0.28	-0.27	-0.09	-0.15		0.2	0.11	-0.18	0.18	0.16	0.1	-0.16	-0.16	0.14	-0.13	-0.09
Property Plant Equipment	0.88	0.0	0.86	0.49	-0.9	0.6	0.78	0.61	0.79	0.2		-0.52	0.92	-0.85	-0.78	-0.4	0.77	0.78	-0.67	0.63	0.36
Good Will	-0.09	-0.08	-0.53	-0.63	0.72	-0.78	-0.77	-0.01	-0.26	0.11	-0.52		-0.5	0.83	0.68	0.94	-0.62	-0.74	0.87	-0.86	-0.89
Capital Surpluse	0.79	-0.17	0.94	0.35	-0.94	0.7	0.88	0.66	0.85	-0.18	0.92	-0.5		-0.88	-0.82	-0.36	0.81	0.82	-0.68	0.63	0.3
Intangible Assets	-0.58	0.08	-0.9	-0.55	0.98	-0.78	-0.91	-0.45	-0.72	0.18	-0.85	0.83	-0.88		0.87	0.75	-0.85	-0.89	0.88	-0.85	-0.71
Current Deferred Revenue	-0.55	-0.32	-0.71	-0.67	0.9	-0.78	-0.79	-0.16	-0.49	0.16	-0.78	0.68	-0.82	0.87		0.58	-0.99	-0.98	0.86	-0.81	-0.54
Deferred Long Term Liab	-0.04	-0.08	-0.47	-0.58	0.64	-0.57	-0.58	0.02	-0.24	0.1	-0.4	0.94	-0.36	0.75	0.58		-0.56	-0.61	0.79	-0.8	-0.99
Net Invested Capital	0.58	0.34	0.72	0.7	-0.89	0.69	0.75	0.17	0.5	-0.16	0.77	-0.62	0.81	-0.85	-0.99	-0.56		0.97	-0.87	0.83	0.52
Capital Stock	0.49	0.31	0.71	0.73	-0.9	0.83	0.86	0.13	0.45	-0.16	0.78	-0.74	0.82	-0.89	-0.98	-0.61	0.97		-0.92	0.88	0.55
Net Working Capital	-0.32	-0.26	-0.66	-0.84	0.83	-0.71	-0.85	-0.05	-0.38	0.14	-0.67	0.87	-0.68	0.88	0.86	0.79	-0.87	-0.92		-1.0	-0.74
Short Term Debt	0.28	0.24	0.63	0.86	-0.79	0.65	0.82	0.03	0.35	-0.13	0.63	-0.86	0.63	-0.85	-0.81	-0.8	0.83	0.88	-1.0		0.76
Short Long Term Debt	0.04	0.07	0.44	0.55	-0.6	0.47	0.5	-0.02	0.24	-0.09	0.36	-0.89	0.3	-0.71	-0.54	-0.99	0.52	0.55	-0.74	0.76

Click cells to compare fundamentals

About Celularity Financial Statements

Celularity shareholders use historical fundamental indicators, such as Net Debt, to determine how well the company is positioned to perform in the future. Although Celularity investors may analyze each financial statement separately, they are all interrelated. The changes in Celularity's assets and liabilities, for example, are also reflected in the revenues and expenses on on Celularity's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	39 M	41 M
Net Debt To EBITDA	(0.35)	(0.37)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Celularity Net Debt from 2010 to 2024

Latest Celularity's Net Debt Growth Pattern

Celularity Net Debt Regression Statistics

Celularity Net Debt History

Other Fundumenentals of Celularity

Celularity Net Debt component correlations

About Celularity Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Celularity Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY